aTyr Pharma | LIFE - Assets

Stock Price
0.50
Daily Change
-0.06 -9.98%
Monthly
-39.31%
Yearly
-84.59%
Q2 Forecast
0.49

aTyr Pharma reported $79.65M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Ardelyx USD 504.51M 2.9M Mar/2026
aTyr Pharma USD 79.65M 435.68M Mar/2026
Biogen USD 29.48B 43.6M Mar/2026
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Curis USD 19.97M 9.27M Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Grifols EUR 23.15B 142.7M Dec/2025
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
United Therapeutics USD 6.71B 1.17B Mar/2026
Xoma USD 263.15M 39.7M Sep/2025